BaseLaunch, a Basel Area-based incubator and accelerator that helps scientists and entrepreneurs launch biotech companies, announced Roche has become a founding partner in the next phase of its company building activities. In addition, BaseLaunch has increased the funding available per venture to $0.5 million to support early stage innovation. During 2018 and 2019, BaseLaunch supported nine early therapeutic ventures which have raised more than $100 million in capital from U.S. and European v...